Effect of Tripterygium wilfordii Extract on Kidney Disease in Mice
Author Information
Author(s): Tao Xuelian, Fan Fred, Hoffmann Victoria, Longo Nancy S, Lipsky Peter E
Primary Institution: National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health
Hypothesis
Can the ethyl acetate extract of Tripterygium wilfordii Hook F improve kidney disease in NZB/W F1 mice with systemic lupus erythematosus?
Conclusion
The ethyl acetate extract of Tripterygium wilfordii significantly improved kidney disease in NZB/W F1 mice.
Supporting Evidence
- Mice treated with the extract showed significantly less proteinuria compared to the vehicle group.
- Histological examination revealed less severe kidney damage in extract-treated mice.
- The extract did not significantly affect levels of anti-dsDNA antibodies.
Takeaway
This study tested a herbal medicine on sick mice and found it helped their kidneys get better.
Methodology
NZB/W F1 mice were divided into three groups and treated with either vehicle or two doses of the extract for 14 weeks, followed by assessments of kidney function and pathology.
Potential Biases
Potential bias in treatment allocation and observer assessment of outcomes.
Limitations
The study was conducted on mice, and results may not directly translate to humans.
Participant Demographics
48 female NZB/W F1 mice, aged 28 weeks.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website